The course material will be a combination of anterior and posterior segment clinical scenarios, translational research, and bench investigation.
Topics Include: Glaucoma pharmaceuticals (including new FDA-approved drugs) • New outflow concepts for the trabecular and uveoscleral pathways • Structural imaging and functional assessment synergy • Surgical experience (from minimally invasive glaucoma surgeries to cataracts/glaucoma surgery to clinical trials results for glaucoma shunts) • New clinical practice regulatory requirements • IRIS registry